Last reviewed · How we verify
SRSD107
At a glance
| Generic name | SRSD107 |
|---|---|
| Sponsor | Sirius Therapeutics Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA (PHASE2)
- A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease (PHASE2)
- A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SRSD107 CI brief — competitive landscape report
- SRSD107 updates RSS · CI watch RSS
- Sirius Therapeutics Co., Ltd. portfolio CI